Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets
Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets

Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets

Abhinav Lahoti Article rating: 3.0

Sequent Scientific Limited announced that it has got European Union good manufacturing practices (EU GMP) approval, which is considered as the highest recognition available by companies in the pharmaceutical space for its tablets dosage manufacturing line in Turkey.

Stocks likely to buzz on bourses today
Stocks likely to buzz on bourses today

Stocks likely to buzz on bourses today

DSIJ Intelligence-3 Article rating: 3.5

5Paisa Capital: Q1FY22 began with a healthy top-line growth of 22 per cent QoQ and 44 per cent YoY. Revenue growth is driven by robust growth in customer base as well as cross-sell income. The company onboarded more than 2,78,000 new clients during the quarter, taking the total number of registered customers to 16.3 lakh.

Gensol Engineering rises on securing contract worth Rs 31.75 crore
Gensol Engineering rises on securing contract worth Rs 31.75 crore

Gensol Engineering rises on securing contract worth Rs 31.75 crore

DSIJ Intelligence Article rating: 4.2

Gensol Engineering Limited, a company engaged in engineering, procurement & construction (EPC), and solar advisory services, announced today that it has received an order from an esteemed client for the development of a grid-connected ground-mounted solar power generation system. 

Q1 operational update: Sunteck Realty sees disruption in booking momentum due to COVID-19
Q1 operational update: Sunteck Realty sees disruption in booking momentum due to COVID-19

Q1 operational update: Sunteck Realty sees disruption in booking momentum due to COVID-19

DSIJ Intelligence Article rating: 4.3

Mumbai-based Sunteck Realty Ltd saw some disruption in its sales momentum in June quarter due to the second wave of COVID-19. In its operational update, the real estate developer said that it witnessed pre-sales of Rs 176 crore in Q1FY22, down by 53 per cent on a sequential basis. On a year-on-year (YoY) basis, given the low base pre-sales, volumes increased by 74 per cent.  

RSS
First23632364236523662368237023712372Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR